2-Aminothiazole → (R)-1-(1-(3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl)-1-(4-fluorophenyl)-2-phenylethyl)-3-(thiazol-2-yl)urea
반응식
[F:1][C:2]1[CH:3]=[C:4]([C@:15]([NH:30][C:31](=O)[O:32]C(C)=C)([C:23]2[CH:28]=[CH:27][C:26]([F:29])=[CH:25][CH:24]=2)[CH2:16][C:17]2[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=2)[CH:5]=[C:6]([O:8][C:9]([F:14])([F:13])[CH:10]([F:12])[F:11])[CH:7]=1.[NH2:37][C:38]1[S:39][CH:40]=[CH:41][N:42]=1.CN1CCCC1>C1COCC1>[F:1][C:2]1[CH:3]=[C:4]([C@:15]([NH:30][C:31]([NH:37][C:38]2[S:39][CH:40]=[CH:41][N:42]=2)=[O:32])([C:23]2[CH:24]=[CH:25][C:26]([F:29])=[CH:27][CH:28]=2)[CH2:16][C:17]2[CH:18]=[CH:19][CH:20]=[CH:21][CH:22]=2)[CH:5]=[C:6]([O:8][C:9]([F:13])([F:14])[CH:10]([F:12])[F:11])[CH:7]=1참가 물질
반응물 3
생성물 1
시약·촉매·용매 1
반응 조건
- 온도
- 150 °C
실험 절차
(R)-prop-1-en-2-yl 1-(3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl)-1-(4-fluorophenyl)-2-phenylethylcarbamate (15 mg, 0.029 mmol) and 2-aminothiazole (8.2 mg, 0.082 mmol, 2.8 eq), and N-methylpyrrolidine (0.9 μl, 0.3 eq) were stirred in THF (0.3 mL) in a microwave vial. The reaction mixture was heated at 150° C. for 20 min under microwave irradiation. After cooling, the solvent was evaporated. The residue was purified by reverse phase HPLC (20-90% CH3CN in H2O with 0.1% TFA) to give pure (R)-1-(1-(3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl)-1-(4-fluorophenyl)-2-phenylethyl)-3-(thiazol-2-yl)urea as white solids (6.5 mg, yield: 40.6%). 1H NMR (400 MHz, CDCl3-D) δ ppm 7.29 (m, 1H), 7.23-7.18 (m, 3H), 7.16 (t, J=8.0 Hz, 2H), 7.02 (t, J=8.5 Hz, 2H), 6.94-6.89 (m, 4H), 6.71 (d, J=6.82 Hz, 2H), 5.86 (tt, J=47.1, 2.9 Hz, 1H), 3.84-3.75 (m, 2H); LC-MS (ESI) 552.28 (M+H), retention time=4.12 min (10-90% MeOH in H2O with 0.1% TFA in a 4-min run).
후처리
- temperatureAfter cooling
- customthe solvent was evaporated
- customThe residue was purified by reverse phase HPLC (20-90% CH3CN in H2O with 0.1% TFA)
출처 및 근거
- ORD 기록
- ord-b98eec8e3b7d407483713c88e50c17a7
- 출처 데이터셋
- uspto-grants-2010_09
- 특허 번호
- US07790770B2
반응 노트
불러오는 중…